Pulmatrix (PULM) Other Non Operating Income (2014 - 2026)
Pulmatrix (PULM) posted Other Non Operating Income of $108000.0 for Q1 2026, up 370.0% sequentially from -$40000.0 in Q4 2025, and up 235.0% YoY from $32238.8 in Q1 2025.
Pulmatrix (PULM) Other Non Operating Income (2014 - 2026) Analysis & Trends
Pulmatrix has reported Other Non Operating Income for 13 years, with the latest figure at $108000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 235.0% year-over-year to $108000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16000.0 (up 91.75% YoY) and the FY2025 annual result came in at -$204000.0, down 4.08% from the prior year.
- Other Non Operating Income advanced to $108000.0 in Q1 2026 per PULM's latest filing, from -$40000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $108000.0 in Q1 2026 and troughed at -$85000.0 in Q1 2023.
- A 5-year average of -$43411.8 and a median of -$50000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2026: Other Non Operating Income plunged 1180.0% in 2022, then jumped 235.0% in 2026.
- Over 5 years, Other Non Operating Income stood at -$82000.0 in 2022, then soared by 39.02% to -$50000.0 in 2023, then rose by 20.0% to -$40000.0 in 2024, then changed by 0.0% to -$40000.0 in 2025, then jumped by 370.0% to $108000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $108000.0, -$40000.0, and -$41000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -43,000.00 |
| Mar 31, 2025 | -80,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | -52,000.00 |
| Jun 30, 2023 | -61,000.00 |
| Mar 31, 2023 | -85,000.00 |
| Dec 31, 2022 | -82,000.00 |
| Sep 30, 2022 | -54,000.00 |
| Jun 30, 2022 | -51,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Mar 31, 2021 | -22,000.00 |